Therefore, the high expression of HLA-E in advanced stage, high-risk MM patients may predict poor prognosis, indicating that HLA-E could be considered as a treatment target, especially for high-risk MM patients. The gene discussed is HLA-E; the disease is Miyoshi myopathy.